Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GOCO vs NCNO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NCNO Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

NCNO Overall Winner 6-Pillar Tally: GOCO 0 – 6 NCNO Matrix Metrics: GOCO 0 – 10 NCNO

As of Nov 17, 2026, nCino, Inc. (NCNO) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas NCNO carries 49.3/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin).

  • Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GOCO vs NCNO
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88
NCNO NASDAQ Head-to-Head Winner
nCino, Inc. Common Stock
Services-Prepackaged Software
$22.43
-1.51% 1D
Market Cap $2.4B
TTM Revenue $622M
Forward P/E 22.2x
Beta / 30D Vol 0.40β · 38% Vol
Unified Composite Score
49.3 / 100 HOLD
Tech 38.0 Fund 53.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 53
RSI-14: 53.2 · SMA20: $22.80 · SMA50: $21.19

6-Pillar Scorecard Institutional Category Breakdown (GOCO 0 – 6 NCNO)

Columns: Metric · GOCO · NCNO
1. Valuation Multiples NCNO
Forward P/E N/M 22.2x
Trailing P/E N/M 71.1x
PEG Ratio N/M N/M
EV / Revenue 0.1x 4.3x
2. Growth & Scale NCNO
Revenue Growth (YoY) -94.6% +8.2%
Earnings Growth (YoY) +424.1% +147.6%
TTM Revenue (USD) $153M $622M
Market Cap $8.5M $2.4B
3. Profitability & Quality NCNO
Gross Margin 57.3% 62.2%
Operating Margin -292.0% 8.2%
Net Profit Margin -189.7% 5.4%
Return on Equity (ROE) -289.9% 3.9%
4. Balance Sheet & Cash Flow NCNO
Cash Generation (TTM) -$148M EBITDA $132M
Cash Flow Margin -96.9% EBITDA Mgn 21.2%
Net Cash / Leverage $0.13 Book/Sh · -289.9% ROE $255M Net Debt (0.36x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NCNO
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 55.7% (20th %ile)
Put/Call OI Skew N/A 0.02x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat NCNO
OpEx & R&D Intensity N/A 54.0% of Rev ($336M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GOCO (0) vs NCNO (10)
Institutional Metric GOCO NCNO Criterion Row Edge
Market Capitalization
Scale
$8.5M $2.4B Larger Scale NCNO
Trailing P/E Ratio
Valuation
N/M 71.1x Lower Multiple NCNO
Forward P/E Ratio
Valuation
N/M 22.2x Lower Multiple NCNO
Revenue Growth (YoY)
Growth
-94.6% +8.2% Higher Growth NCNO
Operating Margin (TTM)
Profitability
-292.0% 8.2% Higher Margin NCNO
Net Profit Margin
Profitability
-189.7% 5.4% Higher Margin NCNO
Return on Equity (ROE)
Capital Efficiency
-289.9% 3.9% Higher ROE NCNO
52-Week Range Position
Momentum
0% ($0–$7) 63% ($14–$28) Stronger Trend NCNO
Beta / 30D Volatility
Risk Regime
2.15β · 201% Vol 0.40β · 38% Vol Lower Realized Risk NCNO
Unified Institutional Score
Composite Signal
42.9 / 100 (HOLD) 49.3 / 100 (HOLD) Higher Composite NCNO
Trailing 12M Revenue (USD)
Operating Scale
$153M $622M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
57.3% 62.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 4.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) $132M ($255M Net Debt (0.36x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NCNO +65.58 pp
GOCO: -64.69% · NCNO: +0.89%
3M Horizon NCNO +78.37 pp
GOCO: -81.52% · NCNO: -3.15%
6M Horizon NCNO +47.43 pp
GOCO: -90.56% · NCNO: -43.13%
1Y Horizon NCNO +45.73 pp
GOCO: -87.97% · NCNO: -42.24%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GOCO vs NCNO. Trailing 12-month operating profitability (GOCO -292.0% vs NCNO 8.2%) and valuation multiples (GOCO N/M vs NCNO 22.2x Forward P/E) are benchmarked directly in Pillar 4 below.

GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M
NCNO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$622M
Gross Margin62.2%
Op. Margin8.2%
ROE / Fwd P/E3.9% · 22.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NCNO CONSOLIDATION
52d in phase · OBV DISTRIBUTION
Current IV 55.7%
IV Percentile 20th %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact NCNO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
NCNO Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $2.4B market capitalization and 8.2% operating margin.
OpEx & R&D Reinvestment 54.0% of Rev ($336M)
90D Engineering Disclosures 0 Published

Investor FAQ GOCO vs NCNO Key Questions & Quantitative Answers

As of Nov 17, 2026, nCino, Inc. (NCNO) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas NCNO carries 49.3/100 (HOLD) at $22.43 (22.2x Forward P/E, 8.2% operating margin). Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile NCNO trades in a Markup technical trend (CONSOLIDATION options phase, RSI 53.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NCNO leads the Growth & Scale pillar: GOCO posts -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin), compared with NCNO at +8.2% YoY revenue growth and +147.6% YoY earnings growth on $622M TTM revenue (62.2% gross margin, 8.2% operating margin). On trailing 12-month operating scale, GOCO generates $153M in USD-normalized revenue versus $622M for NCNO. In operating R&D and SG&A reinvestment, GOCO deploys N/A (0 90-day corporate R&D disclosures) versus 54.0% of Rev ($336M) (0 disclosures) for NCNO.

NCNO screens cheaper on headline valuation multiples. GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin), whereas NCNO trades at 22.2x Forward P/E, 71.1x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (21.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GOCO (-289.9% ROE) versus NCNO (3.9% ROE) capital efficiency.

In options market volatility and institutional positioning, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk). By comparison, NCNO carries 55.7% implied volatility (20th %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.40β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.